A critical evaluation of the South African state antiretroviral programme

Southern African Journal of HIV Medicine

Volumn , Issue 20, 2005, Pages 21-28

  Venter, W D Francois ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; AZITHROMYCIN; DIDANOSINE; EFAVIRENZ; NEVIRAPINE; STAVUDINE;

ARTICLE; GEOGRAPHIC DISTRIBUTION; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; INFECTION COMPLICATION; LACTIC ACIDOSIS; LIFESTYLE; NUTRITIONAL HEALTH; PANCREATITIS; PATIENT COMPLIANCE; PATIENT COUNSELING; PERIPHERAL NEUROPATHY; POPULATION DISTRIBUTION; POPULATION RESEARCH; PUBLIC HEALTH SERVICE; RESOURCE MANAGEMENT; SOUTH AFRICA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STEVENS JOHNSON SYNDROME; TREATMENT FAILURE;

EID: 27844527498     PISSN: 16089693     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. South African Department of Health, Full Report of the Joint Health and Treasury Task Team Charged with Examining Treatment Options to Supplement Comprehensive Care for HIV/AIDS in the Public Health Sector, November 2003. http://www.gov.za/issues/hiv/careplan19nov03.htm (last accessed 5 September 2005).
2. National Antiretroviral Treatment Guidelines. Pretoria: South African National Department of Health, Jacana, 2004.
3. Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004; 18: 887-895.
4. Hudspeth J, Venter WDF, Van Rie A, Wing J, Feldman C. Access to and early outcomes of a public South African adult antiretroviral clinic. S Afr J Epidemiol Infect 2004; 19: 48-51.
5. Ive P, Conradie F, Xaba S, Sanne I, Causes of loss to follow-up in patients taking antiretroviral therapy in the national rollout program of South Africa, 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, 24-27 July 2005. Abstract MoPp0304.
6. Conradie F, Ive P, Sanne I, Boulme R, Gender differences in ART initiates at Helen Joseph Hospital (HJH), in the National Antiretroviral programme of South Africa, 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, 24-27 July 2005. Abstract MoPe11.1C29.
7. Bekker L-G, Orrell C, Pitt J, Abdullah F, Wood R. Are the early results reported from community antiretroviral programs in South Africa durable with increasing numbers and time? 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, 24-27 July 2005. Abstract MoPp0302.
8. Egbers C, Moultrie H, Meyers T. Audit of HIV-infected children on antiretroviral treatment on the government rollout program at a tertiary hospital, Soweto, South Africa. 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, 24-27 July 2005. Abstract MoPe11.7C14.
9. Bock P, Cloete K, Channing L, et al. Cohort study of programmatic outcomes of patients on antiretrovirals in the public sector in the Western Cape Province, South Africa. 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, 24-27 July 2005. Abstract MoPe11.6C13.
10. Van Cutsem G, Boulle A, Sarunchuk P, et al. Regimen durability and tolerability and reasons for regimen changes in the first 1,000 treatment-naïve adults accessing ART in Khayelitsha. 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, 24-27 July 2005. Abstract TuPe11.8C10.
11. Boulle A, Coetzee D, Hilderbrand K, Goemaere E. When to switch regimens: the Khayelitsha experience. 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janieno, 24-27 July 2005. Abstract WePe12.9C15.
12. Matchaba G, Mahlati T, Ntshani E. Patient-centered pharmaceutical care for HIV-infected patients: Creation of a critical role for pharmacists in South Africa. 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, 24-27 July 2005. Abstract MoPe11.2C14.
13. Johnson J, Li JF, Morris L, et al. Resistance emerges in the majority of women provided intrapartum single-dose nevirapine. Program and abstracts of the 12th Conference on Retroviruses and Opportunistic Infections, 22-25 February, 2005. Boston, Abstract 100.
14. Demographics. http://en.wikipedia.org/wiki/Demographics_of_South_Africa (last accessed 5 September 2005).
15. Shisana O. Nelson Mandela/HSRC Study of HIV/AIDS: South African National HIV Prevalence, Behavioural Risks and Mass Media: Household Survey 2002. http://www.hsrcpublishers.co.za/user_uploads/tblPDF/ 2009_00_Nelson_Mandela_HIV_Full_Report.pdf (last accessed 5 September 2005).